Browsing byAuthorYoon D.H.

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 13 of 13

Issue DateTitleAuthor(s)Type
2023A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients with Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone문영철Article
2014Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in Korea문영철Article
2012Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)문영철Article
2021Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone문영철Article
2021Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia문영철Article
2017Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy문영철Article
2021Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia문영철Article
2017Improved prognostic stratification using NCCN- and GELTAMOinternational prognostic index in patients with diffuse large B-cell lymphoma문영철Article
2022Optimal timing of treatment at relapse after autologous stem cell transplantation in patients with multiple myeloma: a study of the Korean Multiple Myeloma Working Party (KMM-1909)문영철Article
2022Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma문영철Article
2022TAZ promotes PDX1-mediated insulinogenesis황은숙Article
2017The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: A retrospective multicenter study (KMM160)문영철Article
2015Treatment outcomes of rituximab plus hyper-CVAD in korean patients with sporadic burkitt or burkitt-like lymphoma: Results of a multicenter analysis문영철Article

BROWSE